Studies shown below have records matching your search criteria.
Results are ordered by most recent first
Select the Study Titles to access a summary of the data and a link to the Study Document
Total records returned by search 69
Page 7 of 7. Page 1 Page 2 Page 3 Page 4 Page 5 Page 6
Records 61 to 69
Expenditures for routine immunization have increased from $6 before GAVI, to $9.2 one year in, to projected $17.5 per infant for 2005-10. Scale up of immunization during this latter period must therefore increase by a factor of three compared to baseline. In addition, the review found that...
Effect of the Global Alliance for Vaccines and Immunisation on Diphtheria, Tetanus, and Pertussis Vaccine Coverage: an Independent Assessment.In countries with DTP3 coverage of 65% or less at baseline, ISS spending per surviving child had a significant positive effect on DTP3 coverage (p=00005). This effect was not present in countries with DTP3 coverage of 6580% or 80% or more at baseline. If ISS expenditure only is assessed, the estimated cost per additional child immunised in countries with baseline coverage of 65% or less is US$14 and if ISS and non-ISS expenditures are included the cost per child is almost $20.
This evaluation of GAVI's Phase 1 performance presents findings on its programmes and activities, and it management and sustainability approaches.
New Products into Old Systems: The Initial Impact of the Global Alliance for Vaccines and Immunization (GAVI) at Country Level.Whilst all countries welcomed the renewed focus on immunisations, strengthening of country immunisation coordination committees, introduction of Hepatitis B vaccine with safe injection equipment, and flexible systems support funding, the pace of the application process was too rapid for all countries studied, contrasting sharply with delays in vaccine delivery.
Tracking Progress towards Universal Childhood Immunisation and the Impact of Global Initiatives: a Systematic Analysis of Three-Dose Diphtheria, Tetanus, and Pertussis Immunisation Coverage.Crude coverage of DTP3 based on surveys increased from 59% in 1986 to 74% in 2006. Substantial differences identified between officially reported and survey-based coverage during Universal Childhood Immunisation (UCI).
Lessons Learned in the Field Health Financing and Governance: A Report on the Country Coordinating Mechanism Model.Findings on Global Fund partnership and leadership, governance and Civil Society participation, and CCM practices are presented in this evaluation. Read more...
An Analysis of the Gender Policies of the Three Major AIDS Financing Institutions: The Global Fund to Fight AIDS, Tuberculosis and Malaria, the World Bank and the Presidents Emergency Plan for AIDS Relief.Findings are presented on the Global Fund, PEPFAR, and the World Bank's incorporation of gender policies into their programs and projects.
Investment in HIV/AIDS programs: Does it help strengthen health systems in developing countries?
- Although accounts of positive and negative effects of GHI and other partners AIDS funding are readily asserted, available evidence on the effects of the scaled-up response to HIV/AIDS on health systems is slim.
- GHIs are adopting measures to further strengthen health systems while targeting their focused diseases.
The Numbers Behind the Stories: PEPFAR Funding for Fiscal Years 2004 to 2006.The President's Emergency Plan for AIDS Relief (PEPFAR) does not regularly release detailed information about how it spends its money. The Report recommends that PEPFAR publish official data on obligations to prime recipients and sub-recipients to improve transparency and accountability. This would permit cost effectiveness analyses and strengthen coordination with other stakeholders, amongst other things.
Further information can be obtained from Aisling Walsh or from Neil Spicer, or from any of the individual country researchers.
Last Updated: Friday 16th November 2007
AA | XHTML | CSS.